Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery

Quality of Life Research

Volumn 23, Issue 4, 2014, Pages 1097-1115

  Jacobs, M ^a   Macefield, R C ^b   Elbers, R G ^c   Sitnikova, K ^a   Korfage, I J ^d   Smets, E M A ^a   Henselmans, I ^a   Van Berge Henegouwen, M I ^c   De Haes, J C J M ^a   Blazeby, J M ^b,e   Sprangers, M A G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Esophageal cancer; Health related quality of life; Meta analysis; Patient reported outcomes; Surgery

Indexed keywords

ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FATIGUE; HEALTH STATUS; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SURVIVOR; TIME;

COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FATIGUE; HEALTH STATUS; HUMANS; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVORS; TIME FACTORS;

EID: 84897383013     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0545-z     Document Type: Review

References (68)

1. Gebski, V.; Burmeister, B.; Smithers, B. M.; Foo, K.; Zalcberg, J.; Simes, J. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. The Lancet Oncology, 8(3), 226-234.
2. Rutegard, M.; Charonis, K.; Lu, Y.; Lagergren, P.; Lagergren, J.; Rouvelas, I. (2012). Population-based esophageal cancer survival after resection without neoadjuvant therapy: An update. Surgery, 152(2), 903-910.
3. Van, H. P.; Hulshof, M. C.; van Lanschot, J. J.; Steyerberg, E. W.; van Berge Henegouwen, M. I.; Wijnhoven, B. P.; et al. (2012). Preoperative chemoradiotherapy for esophageal or junctional cancer. New England Journal of Medicine, 366(22), 2074-2084.
4. Djarv, T.; Lagergren, P. (2012). Quality of life after esophagectomy for cancer. Expert Review of Gastroenterology & Hepatology, 6(1), 115-122.
5. Trask, P. C.; Hsu, M. A.; McQuellon, R. (2009). Other paradigms: Health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer Journal, 15(5), 435-440.
6. Henselmans, I.; Jacobs, M.; van Berge Henegouwen, M. I.; de Haes, H. C.; Sprangers, M. A.; Smets, E. M. (2012). Postoperative information needs and communication barriers of esophageal cancer patients. Patient Education and Counseling, 88(1), 138-146.
7. Higgins J. P. T.; Green, S. (Eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Accessed August 27, 2012.
8. Guyatt, G. H.; Oxman, A. D.; Vist, G.; Kunz, R.; Brozek, J.; Alonso-Coello, P.; et al. (2011). GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). Journal of Clinical Epidemiology, 64(4), 407-415.
9. Whistance, R. N.; Blazeby, J. M. (2011). Systematic review: Quality of life after treatment for upper gastrointestinal cancer. Current Opinion in Supportive and Palliative Care, 5(1), 37-46.
10. Conroy, T.; Marchal, F.; Blazeby, J. M. (2006). Quality of life in patients with oesophageal and gastric cancer: An overview. Oncology, 70(6), 391-402.
11. Parameswaran, R.; McNair, A.; Avery, K. N.; Berrisford, R. G.; Wajed, S. A.; Sprangers, M. A.; et al. (2008). The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: A systematic review. Annals of Surgical Oncology, 15(9), 2372-2379.
12. Sanghera, S. S.; Nurkin, S. J.; Demmy, T. L. (2012). Quality of life after an esophagectomy. Surgical Clinics of North America, 92(5), 1315-1335.
13. Fernandez, F. G.; Meyers, B. F. (2004). Quality of life after esophagectomy. Seminars in Thoracic and Cardiovascular Surgery, 16(2), 152-159.
14. Jacobs, M.; Macefield, R. C.; Blazeby, J. M.; Korfage, I. J.; van Berge Henegouwen, M. I.; de Haes, H. C.; et al. (2012). Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Quality of Life Research,. doi: 10.1007/s11136-012-0290-8.
15. Borenstein, M.; Hedges, L. V.; Higgins, J. P.; Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester: Wiley.
16. Scarpa, M.; Valente, S.; Alfieri, R.; Cagol, M.; Diamantis, G.; Ancona, E.; et al. (2011). Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World Journal of Gastroenterology, 17(42), 4660-4674.
17. Maringwa, J. T.; Quinten, C.; King, M.; Ringash, J.; Osoba, D.; Coens, C.; et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753-1760.
18. Shrier, I.; Boivin, J. F.; Steele, R. J.; Platt, R. W.; Furlan, A.; Kakuma, R.; et al. (2007). Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. American Journal of Epidemiology, 166(10), 1203-1209.
19. Ioannidis, J. P.; Patsopoulos, N. A.; Rothstein, H. R. (2008). Reasons or excuses for avoiding meta-analysis in forest plots. British Medical Journal, 336(7658), 1413-1415.
20. Vandenbroucke, J. P. (2011). Why do the results of randomised and observational studies differ? British Medical Journal, 343, d7020.
21. Avery, K. N.; Metcalfe, C.; Barham, C. P.; Alderson, D.; Falk, S. J.; Blazeby, J. M. (2007). Quality of life during potentially curative treatment for locally advanced oesophageal cancer. British Journal of Surgery, 94(11), 1369-1376.
22. Howick, J.; Chalmers, I.; Glasziou, P.; Greenhalgh, T.; Heneghan, C.; Liberati, A. et al. (2011). Explanation of the 2011 Oxford centre for evidence-based medicine (OCEBM) levels of evidence (Background Document). Oxford centre for evidence-based medicine. http://www.cebm.net/index.aspx?o=5653. Accessed 27 August 2012.
23. Efficace, F.; Bottomley, A.; Osoba, D.; Gotay, C.; Flechtner, H.; D'haese, S.; et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials-does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21, 3502-3511.
24. Blazeby, J. M.; Conroy, T.; Hammerlid, E.; Fayers, P.; Sezer, O.; Koller, M.; et al. (2003). Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. European Journal of Cancer, 39(10), 1384-1394.
25. Blazeby, J. M.; Alderson, D.; Winstone, K.; Steyn, R.; Hammerlid, E.; Arraras, J.; et al. (1996). Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. European Journal of Cancer, 32(11), 1912-1917.
26. DerSimonian, R.; Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177-188.
27. Riley, R. D.; Higgins, J. P.; Deeks, J. J. (2011). Interpretation of random effects meta-analyses. British Medical Journal, 342, d549.
28. Higgins, J. P.; Thompson, S. G.; Deeks, J. J.; Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327(7414), 557-560.
29. Higgins, J. P.; Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539-1558.
30. Ioannidis, J. P.; Patsopoulos, N. A.; Evangelou, E. (2007). Uncertainty in heterogeneity estimates in meta-analyses. British Medical Journal, 335(7626), 914-916.
31. Cocks, K.; King, M. T.; Velikova, G.; de, C. G.; Jr.; Martyn St-James, M.; Fayers, P. M. et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713-1721.
32. Osoba, D.; Rodrigues, G.; Myles, J.; Zee, B.; Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139-144.
33. Cohen, J. (1988). Statistical power analysis in the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates Inc.
34. Boshier, P. R.; Anderson, O.; Hanna, G. B. (2011). Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: A meta-analysis. Annals of Surgery, 254(6), 894-906.
35. Hulscher, J. B.; van Sandick, J. W.; de Boer, A. G.; Wijnhoven, B. P.; Tijssen, J. G.; Fockens, P.; et al. (2002). Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine, 347(21), 1662-1669.
36. Chang, A. C.; Ji, H.; Birkmeyer, N. J.; Orringer, M. B.; Birkmeyer, J. D. (2008). Outcomes after transhiatal and transthoracic esophagectomy for cancer. Annals of Thoracic Surgery, 85(2), 424-429.
37. Rutegard, M.; Lagergren, J.; Rouvelas, I.; Lindblad, M.; Blazeby, J. M.; Lagergren, P. (2008). Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. British Journal of Surgery, 95(5), 592-601.
38. Yang, K.; Chen, H. N.; Chen, X. Z.; Lu, Q. C.; Pan, L.; Liu, J.; et al. (2012). Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: A meta-analysis. PLoS ONE, 7(6), e37698.
39. Sjoquist, K. M.; Burmeister, B. H.; Smithers, B. M.; Zalcberg, J. R.; Simes, R. J.; Barbour, A.; et al. (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis. The Lancet Oncology, 12(7), 681-692.
40. Fedeli, U.; Schievano, E.; Lisiero, M. (2012). Mortality after esophageal and gastric cancer resection. World Journal of Surgery, 36(11), 2630-2636.
41. Biere, S. S.; Maas, K. W.; Bonavina, L.; Garcia, J. R.; van Berge Henegouwen, M. I.; Rosman, C.; et al. (2011). Traditional invasive versus minimally invasive esophagectomy: A multi-center, randomized trial (TIME-trial). British Medical Journal Surgery, 11, 2.
42. Shah, R.; Jobe, B. A. (2011). Open versus minimally invasive esophagectomy: What is the best approach? Minimally invasive esophagectomy. Journal of Gastrointestinal Surgery, 15(9), 1503-1505.
43. Duval, S.; Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455-463.
44. Rosenthal, R. (1979). The 'file drawer problem' and tolerance for null results. Psychological Bulletin, 86, 638-641.
45. Egger, M.; Davey, S. G.; Schneider, M.; Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629-634.
46. Teoh, A. Y.; Yan Chiu, P. W.; Wong, T. C.; Liu, S. Y.; Hung Wong, S. K.; Ng, E. K. (2011). Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation: Results from a randomized trial. Annals of Surgery, 253(1), 1-5.
47. Nafteux, P.; Moons, J.; Coosemans, W.; Decaluwe, H.; Decker, G.; De, L. P.; et al. (2011). Minimally invasive oesophagectomy: A valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. European Journal of Cardio-Thoracic Surgery, 40(6), 1455-1463.
48. Parameswaran, R.; Blazeby, J. M.; Hughes, R.; Mitchell, K.; Berrisford, R. G.; Wajed, S. A. (2010). Health-related quality of life after minimally invasive oesophagectomy. British Journal of Surgery, 97(4), 525-531.
49. Wang, H.; Tan, L.; Feng, M.; Zhang, Y.; Wang, Q. (2011). Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy. Quality of Life Research, 20(2), 179-189.
50. Wang, H.; Feng, M.; Tan, L.; Wang, Q. (2010). Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Diseases of the Esophagus, 23(5), 408-414.
51. Safieddine, N.; Xu, W.; Quadri, S. M.; Knox, J. J.; Hornby, J.; Sulman, J.; et al. (2009). Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention. Journal of Thoracic and Cardiovascular Surgery, 137(1), 36-42.
52. van Meerten, E.; van der Gaast, A.; Looman, C. W.; Tilanus, H. W.; Muller, K.; Essink-Bot, M. L. (2008). Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. International Journal of Radiation Oncology Biology Physics, 71(1), 160-166.
53. Barbour, A. P.; Lagergren, P.; Hughes, R.; Alderson, D.; Barham, C. P.; Blazeby, J. M. (2008). Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. British Journal of Surgery, 95(1), 80-84.
54. Lagergren, P.; Avery, K. N. L.; Hughes, R.; Barham, C. P.; Alderson, D.; Falk, S. J. et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110(3), 686-693.
55. Tan, Q. Y.; Wang, R. W.; Jiang, Y. G.; Fan, S. Z.; Hsin, M. K.; Gong, T. Q.; et al. (2006). Lung volume reduction surgery allows esophageal tumor resection in selected esophageal carcinoma with severe emphysema. Annals of Thoracic Surgery, 82(5), 1849-1856.
56. Reynolds, J. V.; McLaughlin, R.; Moore, J.; Rowley, S.; Ravi, N.; Byrne, P. J. (2006). Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. British Journal of Surgery, 93(9), 1084-1090.
57. de Boer, A. G.; van Lanschot, J. J.; van Sandick, J. W.; Hulscher, J. B.; Stalmeier, P. F.; de Haes, J. C.; et al. (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Journal of Clinical Oncology, 22(20), 4202-4208.
58. Brooks, J. A.; Kesler, K. A.; Johnson, C. S.; Ciaccia, D.; Brown, J. W. (2002). Prospective analysis of quality of life after surgical resection for esophageal cancer: Preliminary results. Journal of Surgical Oncology, 81(4), 185-194.
59. Scarpa, M.; Saadeh, L. M.; Fasolo, A.; Alfieri, R.; Cagol, M.; Cavallin, F.; et al. (2013). Health-related quality of life in patients with oesophageal cancer: Analysis at different steps of the treatment pathway. Journal of Gastrointestinal Surgery,. doi: 10.1007/s11605-012-2069-1.
60. Biere, S. S.; van Berge Henegouwen, M. I.; Maas, K. W.; Bonavina, L.; Rosman, C.; Garcia, J. R.; et al. (2012). Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet, 379(9829), 1887-1892.
61. Briez, N.; Piessen, G.; Bonnetain, F.; Brigand, C.; Carrere, N.; Collet, D.; et al. (2011). Open versus laparoscopically-assisted oesophagectomy for cancer: A multicentre randomised controlled phase III trial - the MIRO trial. BMC Cancer, 11(310), 310.
62. Zhang, C.; Wu, Q. C.; Hou, P. Y.; Zhang, M.; Li, Q.; Jiang, Y. J.; et al. (2011). Impact of the method of reconstruction after oncologic oesophagectomy on quality of life - a prospective, randomised study. European Journal of Cardio-Thoracic Surgery, 39(1), 109-114.
63. Steyerberg, E. W. (2009). Clinical prediction models. New York: Springer.
64. Derogar, M.; Orsini, N.; Sadr-Azodi, O.; Lagergren, P. (2012). Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. Journal of Clinical Oncology, 30(14), 1615-1619.
65. Sprangers, M. A.; Sloan, J. A.; Barsevick, A.; Chauhan, C.; Dueck, A. C.; Raat, H.; et al. (2010). Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research, 19(10), 1395-1403.
66. Lagergren, J.; Lagergren, P. (2013). Recent developments in esophageal adenocarcinoma. CA: A Cancer Journal for Clinicians,. doi: 10.1002/caac.21185.
67. Wood, L.; Egger, M.; Gluud, L. L.; Schulz, K. F.; Juni, P.; Altman, D. G.; et al. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. British Medical Journal, 336(7644), 601-605.
68. Moher, D.; Pham, B.; Lawson, M. L.; Klassen, T. P. (2003). The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technology Assessment, 7(41), 1-90.